Skip to main content
Premium Trial:

Request an Annual Quote

Xennex Licenses GeneCards Database to European Patent Office

NEW YORK, March 29 (GenomeWeb News) - Xennex has licensed its GeneCards database to the European Patent Office, the Cambridge, Mass.-based company said today.


Patent examiners at the EPO will use GeneCards to review and approve patent applications in the life sciences area. They plan to use the database to conduct prior art research, to determine whether an invention can be patented, and to retrieve information to support other patent-related activities. The product will be available to EPO employees at sites in Munich, Berlin, the Hague, and Vienna. In addition, national patent offices of EPO's member states will have access to the software. Xennex did not disclose financial details of the agreement.


GeneCards, developed by bioinformaticists at the Weizmann Institute of Science in Israel, is a compendium of human genes and their encoded proteins and provides information on functional genomics and medical aspects, including involvement in disease.

The Scan

Single-Cell Sequencing Points to Embryo Mosaicism

Mosaicism may affect preimplantation genetic tests for aneuploidy, a single-cell sequencing-based analysis of almost three dozen embryos in PLOS Genetics finds.

Rett Syndrome Mouse Model Study Points to RNA Editing Possibilities

Investigators targeted MECP2 in mutant mouse models of Rett syndrome, showing in PNAS that they could restore its expression and dial down symptoms.

Investigators Find Shared, Distinct Genetic Contributors to Childhood Hodgkin Lymphoma

An association study in JAMA Network Open uncovers risk variants within and beyond the human leukocyte antigen locus.

Transcriptomic, Epigenetic Study Appears to Explain Anti-Viral Effects of TB Vaccine

Researchers report in Science Advances on an interferon signature and long-term shifts in monocyte cell DNA methylation in Bacille Calmette-Guérin-vaccinated infant samples.